Tissular localization and excretion of intravenously administered silica nanoparticles of different sizes

Journal of Nanoparticle Research

Volumn 14, Issue 1, 2012, Pages

  Xie, Guangping ^a   Sun, Jiao ^a   Zhong, Gaoren ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Excretion; Health effects; Hemoconcentration; Silica nanoparticles; Tissular localization

Indexed keywords

EXCRETION; HEALTH EFFECTS; HEMOCONCENTRATION; SILICA NANOPARTICLES; TISSULAR LOCALIZATION;

BODY FLUIDS;

PHYSIOLOGY;

NANOPARTICLE; RADIOACTIVE MATERIAL; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCRETION; FECES ANALYSIS; FLUORESCENCE MICROSCOPY; HEMOCONCENTRATION; LIVER; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SPLEEN; TISSUE DISTRIBUTION; URINALYSIS;

EID: 84862823678     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-011-0671-x     Document Type: Article

References (30)

1. Burns AA, Vider J, Ow H, Herz E, Penate-Medina O, Baumgart M, Larson SM, Wiesner U, BradburyM(2009) Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9(1):442-448
2. Chapman AP, Antoniw P, Spitali M, West S, Stephens S, King DJ (1999) Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol 17(8):780-783 (Pubitemid 29365106)
3. Chen Z, Chen H, Meng H, Xing G, Gao X, Sun B, Shi X, Yuan H, Zhang C, Liu R, Zhao F, Zhao Y, Fang X (2008) Biodistribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol Appl Pharmacol 230(3):364-371
4. Cho M, Cho WS, Choi M, Kim SJ, Han BS, Kim SH, Kim HO, Sheen YY, Jeong J (2009) The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 189(3):177-183
5. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV (2007a) Renal clearance of quantum dots. Nat Biotechnol 25(10):1165-1170 (Pubitemid 47538116)
6. Choi J, Burns AA, Williams RM, Zhou Z, Flesken-Nikitin A, Zipfel WR, Wiesner U, Nikitin AY (2007b) Core-shell silica nanoparticles as fluorescent labels for nanomedicine. J Biomed Opt 12(6):064007
7. DobrovolskaiaMA, McNeil SE (2007) Immunological properties of engineered nanomaterials.NatNanotechnol 2(8):469-478 (Pubitemid 47220069)
8. Fischer HC, Chan WC (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18(6):565-571
9. Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJ (2007) What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 49(3):217-229 (Pubitemid 350087396)
10. He X, Nie H, Wang K, Tan W, Wu X, Zhang P (2008) In vivo study of biodistribution and urinary excretion of surfacemodified silica nanoparticles. Anal Chem
11. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL (2003) Nanoshellmediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100(23):13549-13554 (Pubitemid 37444779)
12. Huo Q, Liu J, Wang LQ, Jiang Y, Lambert TN, Fang E (2006) A new class of silica cross-linked micellar core-shell nanoparticles. J Am Chem Soc 128(19):6447-6453 (Pubitemid 43727283)
13. Iezzi EB, Duchamp JC, Harich K, Glass TE, Lee HM, Olmstead MM, Balch AL, Dorn HC (2002) A symmetric derivative of the trimetallic nitride endohedral metallofullerene, Sc3 N@C80. J Am Chem Soc 124(4):524-525 (Pubitemid 34101153)
14. Li SD, Huang L (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5(4):496-504
15. Liu Y, Miyoshi H, Nakamura M (2007) Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics. Colloids Surf B Biointerfaces 58(2): 180-187 (Pubitemid 46921455)
16. Liu T, Li L, Teng X, Huang X, Liu H, Chen D, Ren J, He J, Tang F (2011) Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 32(6):1657-1668
17. Lund U, Rippe A, Venturoli D, Tenstad O, Grubb A, Rippe B (2003) Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. Am J Physiol Renal Physiol 284(6):F1226-F1234 (Pubitemid 36578450)
18. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB (2006) Safe handling of nanotechnology. Nature 444(7117):267-269 (Pubitemid 44764087)
19. Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7): 823-839 (Pubitemid 40984181)
20. Ozgo M, Skrzypczak W, Drzezdzon D, Lepczynski A, Dratwa- Chalupnik A, Michalek K, Herosimczyk A (2009) Urinary excretion of low molecular weight proteins in goats during the neonatal period. J Physiol Pharmacol 60(Suppl 3): 119-125
21. Prescott LF, McAuslane JA, Freestone S (1991) The concentration- dependent disposition and kinetics of inulin. Eur J Clin Pharmacol 40(6):619-624
22. Roy I, Ohulchanskyy TY, Bharali DJ, Pudavar HE, Mistretta RA, Kaur N, Prasad PN (2005) Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. Proc Natl Acad Sci USA 102(2):279-284 (Pubitemid 40116758)
23. Slowing II, Trewyn BG, Lin VS (2007) Mesoporous silica nanoparticles for intracellular delivery of membraneimpermeable proteins. J Am Chem Soc 129(28):8845-8849 (Pubitemid 47492073)
24. Takizawa Y, Nishimura H, Morota T, Tomisawa H, Takeda S, AburadaM(2004) Pharmacokinetics of TJ-8117 (Onpi-to), a drug for renal failure (I): Plasma concentration, distribution and excretion of [3H]-(-)epicatechin 3-O-gallate in rats and dogs. Eur J Drug Metab Pharmacokinet 29(2): 91-101 (Pubitemid 38828621)
25. Tsuji JS, Maynard AD, Howard PC, James JT, Lam CW, Warheit DB, Santamaria AB (2006) Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol Sci 89(1):42-50 (Pubitemid 43013753)
26. van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, Tang CY, Gordon RE, Nicolay K, Meijerink A, Fayad ZA, Mulder WJ (2008) Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett 8(8):2517-2525
27. 2 nanoparticles translocation and potential toxicological effect in rats after intraarticular injection. Biomaterials 30(27):4590-4600
28. Xie G, Sun J, Zhong G, Shi L, Zhang D (2010) Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Arch Toxicol 84(3):183-190
29. Yang J, Lee J, Kang J, Lee K, Suh JS, Yoon HG, Huh YM, Haam S (2008) Hollow silica nanocontainers as drug delivery vehicles. Langmuir 24(7):3417-3421 (Pubitemid 351549185)
30. Zhao X, Hilliard LR, Mechery SJ, Wang Y, Bagwe RP, Jin S, Tan W (2004) A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. Proc Natl Acad Sci USA 101(42):15027-15032 (Pubitemid 39391712)